UCBJY UCB SA ADR

USD 61.57 -0.30 -0.484888
Icon

UCB SA ADR (UCBJY) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 61.57

-0.30 (-0.48)%

USD 22.77B

6.21K

USD 0.00(+0.00%)

N/A

Icon

UCBJY

UCB SA ADR (USD)
COMMON STOCK | OTC
USD 61.57
0.00 0
Take a Tour
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 22.77B

N/A

USD 61.57

UCB SA ADR (UCBJY) Stock Forecast

Show ratings and price targets of :
N/A
(+0.00%)

Based on the UCB SA ADR stock forecast from 1 analysts, the average analyst target price for UCB SA ADR is not available over the next 12 months. UCB SA ADR’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of UCB SA ADR is Neutral, which is based on 8 positive signals and 7 negative signals. At the last closing, UCB SA ADR’s stock price was USD 61.57. UCB SA ADR’s stock price has changed by +4.67% over the past week, +16.63% over the past month and +42.39% over the last year.

No recent analyst target price found for UCB SA ADR
No recent average analyst rating found for UCB SA ADR

Company Overview UCB SA ADR

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Croh...Read More

https://www.ucb.com

Allée de la Recherche, 60, Brussels, Belgium, 1070

8,450

December

USD

USA

Adjusted Closing Price for UCB SA ADR (UCBJY)

Loading...

Unadjusted Closing Price for UCB SA ADR (UCBJY)

Loading...

Share Trading Volume for UCB SA ADR Shares

Loading...

Compare Performance of UCB SA ADR Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for UCBJY

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To UCB SA ADR (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S -1.95 (-1.51%) USD599.92B 48.04 5.17

ETFs Containing UCBJY

Symbol Name UCBJY's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About UCB SA ADR (UCBJY) Stock

Based on ratings from 1 analysts UCB SA ADR's stock is Hold . Stock Target Advisor's fundamental analysis is Neutral. The stock has buy, sell and 1 hold ratings.

UCBJY stock's dividend yield is 1.22%. Our analysis grades UCBJY stock's dividend yield at F. This means that UCBJY stock's dividend yield is above 27% of the stocks in the Biotechnology sector in the OTC exchange. Based on this UCBJY may be a poor dividend stock for its sector.

Based on targets from 1 analysts, the average taret price for UCBJY is USD 0.00 over the next 12 months. The maximum analyst target price is USD while the minimum anlayst target price is USD .

UCBJY stock's Price/Earning ratio is 61.86. Our analysis grades UCBJY stock's Price / Earning ratio at F. This means that UCBJY stock's Price/Earning ratio is above 82% of the stocks in the Biotechnology sector in the OTC exchange. Based on this UCBJY may be a overvalued for its sector.

The last closing price of UCBJY's stock was USD 61.57.

The most recent market capitalization for UCBJY is USD 22.77B.

Based on targets from 1 analysts, the average taret price for UCBJY is projected at USD 0.00 over the next 12 months. This means that UCBJY's stock price may go up by +0.00% over the next 12 months.

We can't find any ETFs which contains UCB SA ADR's stock.

As per our most recent records UCB SA ADR has 8,450 Employees.

UCB SA ADR's registered address is Allée de la Recherche, 60, Brussels, Belgium, 1070. You can get more information about it from UCB SA ADR's website at https://www.ucb.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...